Efficacy and Safety of Dupilumab in Patients With Erythrodermic Atopic Dermatitis
Sign Up to like & getrecommendations! Published in 2023 at "JAMA Dermatology"
DOI: 10.1001/jamadermatol.2022.6192
Abstract: This post hoc analysis of 6 randomized, double-blind, placebo-controlled trials assesses the efficacy and safety of dupilumab in patients with erythrodermic atopic dermatitis. read more here.
Keywords: patients erythrodermic; erythrodermic atopic; dupilumab patients; efficacy safety ... See more keywords
Safety of dupilumab in atopic patients during COVID-19 outbreak
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Dermatological Treatment"
DOI: 10.1080/09546634.2020.1771257
Abstract: Since the COVID-19 outbreak, different special measures have been applied in dermatological clinics, in order to reduce the spread of infection among both patients and physicians, with a reduction of face to face visits and… read more here.
Keywords: safety dupilumab; infection; treatment; dupilumab ... See more keywords
Real-life Effectiveness and Safety of Dupilumab in Adult Patients with Moderate-to-Severe Atopic Dermatitis.
Sign Up to like & getrecommendations! Published in 2021 at "Dermatologic therapy"
DOI: 10.1111/dth.15192
Abstract: Atopic dermatitis (AD) is a common, chronic inflammatory condition with a substantial negative impact on the quality of life. Dupilumab, the first biologic approved for the treatment of moderate-to-severe AD, binds IL-4Rα and inhibits signaling… read more here.
Keywords: effectiveness safety; safety dupilumab; dupilumab; real life ... See more keywords
Real-life experience in the effectiveness, impact on quality of life and safety of dupilumab treatment in patients with moderate to severe atopic dermatitis in the Czech Republic.
Sign Up to like & getrecommendations! Published in 2022 at "Central European journal of public health"
DOI: 10.21101/cejph.a6885
Abstract: OBJECTIVES The aim of the study was to assess the effectiveness and safety of dupilumab therapy in patients with moderate-to-severe atopic dermatitis (AD) in a real-life Czech bicentric cohort. METHODS We retrospectively analysed 50 patients… read more here.
Keywords: patients moderate; life; moderate severe; dupilumab ... See more keywords